Low serum haptoglobin and blood films suggest intravascular hemolysis contributes to severe anemia in hereditary hemorrhagic telangiectasia
- PMID: 30337360
- PMCID: PMC6442977
- DOI: 10.3324/haematol.2018.205682
Low serum haptoglobin and blood films suggest intravascular hemolysis contributes to severe anemia in hereditary hemorrhagic telangiectasia
Figures


Similar articles
-
Hereditary hemorrhagic telangiectasia showing severe anemia which was successfully treated with estrogen.Intern Med. 1995 Jun;34(6):589-92. doi: 10.2169/internalmedicine.34.589. Intern Med. 1995. PMID: 7549150
-
Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis.Sci Rep. 2018 Dec 3;8(1):17527. doi: 10.1038/s41598-018-35944-w. Sci Rep. 2018. PMID: 30510258 Free PMC article. Clinical Trial.
-
Hereditary hemorrhagic telangiectasia, liver disease and elevated serum testosterone (Osler-Weber-Rendu syndrome): a case report.BMC Res Notes. 2017 Jan 23;10(1):58. doi: 10.1186/s13104-017-2397-z. BMC Res Notes. 2017. PMID: 28115008 Free PMC article.
-
Hemangioma of the uterus associated with hereditary hemorrhagic telangiectasia.Obstet Gynecol. 1994 Oct;84(4 Pt 2):708-10. Obstet Gynecol. 1994. PMID: 9205458 Review.
-
[Hereditary Hemorrhagic Telangiectasia with iron-deficiency anemia: a case report and literature review].Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):916. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23363747 Review. Chinese. No abstract available.
Cited by
-
Hereditary haemorrhagic telangiectasia.Nat Rev Dis Primers. 2025 Jan 9;11(1):1. doi: 10.1038/s41572-024-00585-z. Nat Rev Dis Primers. 2025. PMID: 39788978 Review.
-
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations.BMJ Case Rep. 2021 Jan 8;14(1):e238385. doi: 10.1136/bcr-2020-238385. BMJ Case Rep. 2021. PMID: 33419752 Free PMC article.
-
Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.Blood. 2019 Sep 26;134(13):1095-1105. doi: 10.1182/blood.2019001040. Epub 2019 Aug 13. Blood. 2019. PMID: 31409673 Free PMC article.
-
Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.J Clin Med. 2023 Dec 15;12(24):7710. doi: 10.3390/jcm12247710. J Clin Med. 2023. PMID: 38137783 Free PMC article.
-
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.Orphanet J Rare Dis. 2019 Feb 4;14(1):28. doi: 10.1186/s13023-018-0982-4. Orphanet J Rare Dis. 2019. PMID: 30717761 Free PMC article.
References
-
- Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;120(4):838–843. - PubMed
-
- Kjeldsen A, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 2000;95(2):415–418. - PubMed
-
- Lund VJ, Darby Y, Rimmer J, et al. Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young’s procedure: a 22-year experience. Rhinology. 2017;55(2):135–141. - PubMed